Group milleri streptococci: Significant pathogens in solid organ recipients

Transplant International

Volumn 20, Issue 1, 2007, Pages 51-56

  Stelzmueller, Ingrid ^a   Berger, Natalie ^a   Wiesmayr, Silke ^a   Eller, Mirjam ^a   Tabarelli, Walther ^a   Fille, Manfred ^a   Margreiter, Raimund ^a   Bonatti, Hugo ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

GHS; Infection; Solid organ transplantation

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPHOTERICIN B; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTRIAXONE; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN A; ERYTHROMYCIN; FLUCLOXACILLIN; FLUCONAZOLE; FOSFOMYCIN; GANCICLOVIR; GENTAMICIN; IMIPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE; STEROID; TACROLIMUS; TOBRAMYCIN; UNINDEXED DRUG;

ABDOMINAL ABSCESS; ABDOMINAL INFECTION; ABSCESS DRAINAGE; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; BILE DUCT OBSTRUCTION; BLEEDING; CHOLANGITIS; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; INTESTINE GRAFT; KIDNEY GRAFT; LAPAROTOMY; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS INTERMEDIUS;

EID: 33845630300     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00396.x     Document Type: Article

References (18)

1. Cuellar-Rodriguez J, Sierra-Madero JG. Infections in solid organ transplant recipients. Rev Invest Clin 2005; 57: 368.
2. Bassetti M, Righi E, Bassetti D. Antimicrobial prophylaxis in solid-organ transplantation. Expert Rev Anti Infect Ther 2004; 2: 761.
3. Wiesmayr S, Stelzmueller I, Tabarelli W, et al. Nocardiosis following solid organ transplantation: a single-centre experience. Transpl Int 2005; 18: 1048.
4. Wiesmayr S, Tabarelli W, Stelzmueller I, et al. Listeria meningitis in transplant recipients. Wien Klin Wochenschr 2005; 117: 229.
5. Piscitelli SC, Shwed J, Schreckenberger P, Danziger LH. Streptococcus miller group: renewed interest in an elusive pathogen. Eur J Clin Microbiol Infect Dis 1992; 11: 491.
6. Clarridge JE, Attorri S, Musher DM, et al. Streptococcus intermedius, Streptococcus constellatus and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess. J Clin Infect Dis 2001; 32: 1511.
7. Belko J, Goldmann DA, Macone A, Zaidi AK. Clinically significant infections with organisms of the Streptococcus milleri group. Pediatr Infect Dis J 2002; 21: 715.
8. Tachopoulou OA, Vogt DP, Henderson JM, Baker M, Keys TF. Hepatic abscess after liver transplantation: 1990-2000. Transplantation 2003; 75: 79.
9. Stelzmueller I, Hoeller E, Wiesmayr S, et al. Severe intraabdominal infection due to Streptococcus milleri following adjustable gastric banding. Obes Surg 2005; 15: 576.
10. Sugihara E, Kido Y, Okamoto M, et al. Clinical features of acute respiratory infections associated with the Streptococcus milleri group in the elderly. Kurume Med J 2004; 51: 53.
11. Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 1992; 30: 243.
12. Zoepf T, Maldonado-Lopez EJ, Hilgard P, et al. Balloon dilatation vs. balloon dilatation plus bile duct endoprostheses for treatment of anastomotic biliary strictures after liver transplantation. Liver Transpl 2006; 12: 88.
13. Zoepf T, Maldonado-Lopez EJ, Hilgard P, et al. Endoscopic therapy of posttransplant biliary stenoses after right-sided adult living donor liver transplantation. Clin Gastroenterol Hepatol 2005; 3: 1144.
14. Porta G, Rodriguez-Carbellaira M, Gomez L, et al. Thoracic infection caused by Streptococcus milleri. Eur Respir J 1998; 12: 357.
15. Yamamoto N, Kubota T, Tohyama M, et al. Trends in antimicrobial susceptibility of the Streptococcus milleri group. J Infect Chemother 2002; 8: 134.
16. Salavert M, Gomez L, Rodriguez-Carballeira M, Xercavins M, Freixas N, Garau J. Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci. Eur J Clin Microbiol Infect Dis 1996; 15: 365.
17. Tracy M, Wanahita A, Shuhatovich Y, Goldsmith EA, Clarridge JE 3rd, Musher DM. Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains. Antimicrob Agents Chemother 2001; 45: 1511.
18. Piscitelli SC, Shwed J, Schreckenberger P, Danziger LH. Streptococcus milleri group: renewed interest in an elusive pathogen. Eur J Clin Microbiol Infect Dis 1992; 11: 491.